PL365735A1 - Antibodies specific for cd44v6 - Google Patents

Antibodies specific for cd44v6

Info

Publication number
PL365735A1
PL365735A1 PL02365735A PL36573502A PL365735A1 PL 365735 A1 PL365735 A1 PL 365735A1 PL 02365735 A PL02365735 A PL 02365735A PL 36573502 A PL36573502 A PL 36573502A PL 365735 A1 PL365735 A1 PL 365735A1
Authority
PL
Poland
Prior art keywords
cd44v6
antibodies specific
antibodies
specific
Prior art date
Application number
PL02365735A
Other languages
English (en)
Polish (pl)
Inventor
Gunther Adolf
Elinborg Ostermann
Erik Patzelt
Marlies Sproll
Karl-Heinz Heider
John J. Miglietta
Dongen Augustinus Antonius Maria Silvester Van
Original Assignee
Boehringer Ingelheim International Gmbh
Boehringer Ingelheim Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc. filed Critical Boehringer Ingelheim International Gmbh
Publication of PL365735A1 publication Critical patent/PL365735A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PL02365735A 2001-05-18 2002-05-17 Antibodies specific for cd44v6 PL365735A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01112237 2001-05-18
US32514701P 2001-09-26 2001-09-26
PCT/EP2002/005467 WO2002094879A1 (en) 2001-05-18 2002-05-17 Antibodies specific for cd44v6

Publications (1)

Publication Number Publication Date
PL365735A1 true PL365735A1 (en) 2005-01-10

Family

ID=33442672

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02365735A PL365735A1 (en) 2001-05-18 2002-05-17 Antibodies specific for cd44v6

Country Status (18)

Country Link
EP (1) EP1397387A1 (xx)
JP (1) JP2005504517A (xx)
CN (1) CN1541226A (xx)
AR (1) AR036154A1 (xx)
BR (1) BR0210905A (xx)
CA (1) CA2443437A1 (xx)
CZ (1) CZ20033476A3 (xx)
EA (1) EA200301169A1 (xx)
EC (1) ECSP034838A (xx)
EE (1) EE200300569A (xx)
HU (1) HUP0400030A3 (xx)
MX (1) MXPA03010523A (xx)
PE (1) PE20021098A1 (xx)
PL (1) PL365735A1 (xx)
SK (1) SK15592003A3 (xx)
WO (1) WO2002094879A1 (xx)
YU (1) YU91403A (xx)
ZA (1) ZA200307365B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071072B2 (en) 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US8048416B2 (en) 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7084257B2 (en) 2001-10-05 2006-08-01 Amgen Inc. Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
US20050232919A1 (en) 2004-02-12 2005-10-20 Morphotek, Inc. Monoclonal antibodies that specifically block biological activity of a tumor antigen
AU2006223301B2 (en) 2005-03-10 2010-11-04 Eisai, Inc. Anti-mesothelin antibodies
EP2172487A1 (en) 2005-04-22 2010-04-07 Morphotek Inc. Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells
LT2167038T (lt) * 2007-06-13 2018-05-25 Zymogenetics, Inc. Taci-ig sulieto baltymo, tokio kaip ataciceptas, panaudojimas gamybai vaisto, skirto raudonajai vilkligei gydyti
EP2009028A1 (en) * 2007-06-27 2008-12-31 Monoclonal Antibodies Therapeutics Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors
PT2531527E (pt) 2010-02-04 2014-05-16 Hoffmann La Roche Anticorpo monoclonal contra cd44 para ser utilizado no tratamento de carcinoma de células escamosas da cabeça e do pescoço
CN102337298B (zh) * 2011-08-19 2013-11-06 黄开红 一种输送siRNA的免疫纳米载体及其制备方法和应用
WO2013083497A1 (en) 2011-12-06 2013-06-13 F. Hoffmann-La Roche Ag Antibody formulation
WO2017215637A1 (zh) * 2016-06-15 2017-12-21 李翀 一种人子宫内膜癌的标志物、抗体及其应用
CN107556388A (zh) * 2016-06-30 2018-01-09 中国科学院深圳先进技术研究院 抗CD44v6和CD3特异性双靶向抗体、含该双靶向抗体表达盒的微环DNA及应用
WO2022187591A1 (en) * 2021-03-05 2022-09-09 Go Therapeutics, Inc. Anti-glyco-cd44 antibodies and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP0438310A1 (en) * 1990-01-19 1991-07-24 Merck & Co. Inc. Method for producing recombinant immunoglobuline
GB9020282D0 (en) * 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
CA2149635A1 (en) * 1992-11-20 1994-06-09 David Tarin Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
UA58482C2 (uk) * 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти
UY24389A1 (es) * 1995-12-06 2001-10-25 Karlsruhe Forschzent Composición farmacéutica para el tratamiento de carcinoma de epitelio plano

Also Published As

Publication number Publication date
YU91403A (sh) 2006-05-25
EP1397387A1 (en) 2004-03-17
JP2005504517A (ja) 2005-02-17
BR0210905A (pt) 2004-06-08
SK15592003A3 (sk) 2004-06-08
EE200300569A (et) 2004-04-15
CN1541226A (zh) 2004-10-27
AR036154A1 (es) 2004-08-18
CZ20033476A3 (cs) 2004-05-12
ZA200307365B (en) 2004-05-10
CA2443437A1 (en) 2002-11-28
MXPA03010523A (es) 2004-07-01
ECSP034838A (es) 2003-12-24
HUP0400030A3 (en) 2006-02-28
EA200301169A1 (ru) 2004-06-24
WO2002094879A1 (en) 2002-11-28
HUP0400030A2 (hu) 2004-04-28
PE20021098A1 (es) 2003-02-11

Similar Documents

Publication Publication Date Title
EP1432444A4 (en) ANTI-BETA ANTIBODIES
HK1074206A1 (en) Anti-trail-r antibodies
EP1467756A4 (en) METHODS OF USING ANTI-MUC18 ANTIBODIES
EP1494693A4 (en) SPECIFIC ANTIBODIES TO CRIPTO
PL375405A1 (en) Antibodies
AU2002256895A1 (en) Anti-TRAIL-R antibodies
EP1616881A4 (en) ANTI-MPL ANTIBODIES
IL175608A0 (en) Antibodies
PT1599504E (pt) Anticorpo modificado
AU2002365649A8 (en) Anti-dota antibody
HUP0400030A3 (en) Antibodies specific for cd44v6
EP1437410A4 (en) NEW SELENOCYSTEIN CONTAINING PROTEINS
IL163580A0 (en) Assay for anti-ingap antibodies
EP1361283A4 (en) NEW ASSAY PROCEDURE
HRP20030931A2 (en) Antibodies specific for cd44v6
GB0226878D0 (en) Antibodies
GB0031284D0 (en) High affinity antibodies
GB0118696D0 (en) Novel antibodies
GB0119553D0 (en) Antibodies
GB0217742D0 (en) Novel antibodies
GB0100750D0 (en) Novel proteins
GB0120494D0 (en) Novel antibody
HK1209139A1 (en) Modified antibody
GB0218229D0 (en) Antibodies
GB0203018D0 (en) Antibodies

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)